OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Immune responses related to the immunogenicity and reactogenicity of COVID-19 mRNA vaccines
Takayuki Matsumura, Tomohiro Takano, Yoshimasa Takahashi
International Immunology (2022) Vol. 35, Iss. 5, pp. 213-220
Open Access | Times Cited: 15
Takayuki Matsumura, Tomohiro Takano, Yoshimasa Takahashi
International Immunology (2022) Vol. 35, Iss. 5, pp. 213-220
Open Access | Times Cited: 15
Showing 15 citing articles:
Opportunities and challenges to implementing mRNA-based vaccines and medicines: lessons from COVID-19
Shehzad Iqbal, Andrew M. Rosen, Darin K. Edwards, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access | Times Cited: 6
Shehzad Iqbal, Andrew M. Rosen, Darin K. Edwards, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access | Times Cited: 6
From Bench to Bedside: Implications of Lipid Nanoparticle Carrier Reactogenicity for Advancing Nucleic Acid Therapeutics
Tetiana Korzun, Abraham S. Moses, Parham Diba, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 8, pp. 1088-1088
Open Access | Times Cited: 16
Tetiana Korzun, Abraham S. Moses, Parham Diba, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 8, pp. 1088-1088
Open Access | Times Cited: 16
Vaccination with the Crimean-Congo hemorrhagic fever virus viral replicon vaccine induces NP-based T-cell activation and antibodies possessing Fc-mediated effector functions
Florine E. M. Scholte, Ercan Karaaslan, Justin T. O’Neal, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 12
Florine E. M. Scholte, Ercan Karaaslan, Justin T. O’Neal, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 12
Effect of mRNA formulated with lipid nanoparticles on the transcriptomic and epigenetic profiles of F4/80+ liver-associated macrophages
Chitsuda Pongma, Pornlapat Keawvilai, Atsadang Boonmee, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Chitsuda Pongma, Pornlapat Keawvilai, Atsadang Boonmee, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Idiopathic granulomatous mastitis after mRNA vaccination against COVID-19: a possible association?
Elisenda Vall, Víctor Araya, Lídia Tortajada, et al.
BJR|case reports (2025) Vol. 11, Iss. 1
Open Access
Elisenda Vall, Víctor Araya, Lídia Tortajada, et al.
BJR|case reports (2025) Vol. 11, Iss. 1
Open Access
Revolutionizing mRNA Vaccines Through Innovative Formulation and Delivery Strategies
Munazza Fatima, Timothy An, Kee‐Jong Hong
Biomolecules (2025) Vol. 15, Iss. 3, pp. 359-359
Open Access
Munazza Fatima, Timothy An, Kee‐Jong Hong
Biomolecules (2025) Vol. 15, Iss. 3, pp. 359-359
Open Access
RNA Vaccines: Yeast as a Novel Antigen Vehicle
Anna Jéssica Duarte Silva, Mylenna Máyra Gois de Sousa, Larissa Silva de Macêdo, et al.
Vaccines (2023) Vol. 11, Iss. 8, pp. 1334-1334
Open Access | Times Cited: 7
Anna Jéssica Duarte Silva, Mylenna Máyra Gois de Sousa, Larissa Silva de Macêdo, et al.
Vaccines (2023) Vol. 11, Iss. 8, pp. 1334-1334
Open Access | Times Cited: 7
ACE mRNA (Additional Chimeric Element incorporated IVT mRNA) for Enhancing Protein Expression by Modulating Immunogenicity
Sora Son, Minsa Park, Jin Kuk Kim, et al.
Advanced Science (2024) Vol. 11, Iss. 18
Open Access | Times Cited: 2
Sora Son, Minsa Park, Jin Kuk Kim, et al.
Advanced Science (2024) Vol. 11, Iss. 18
Open Access | Times Cited: 2
Lymphatic Endothelial Cells Produce Chemokines in Response to the Lipid Nanoparticles Used in RNA Vaccines
Yi Liu, Miho Suzuoki, Hiroki Tanaka, et al.
Biological and Pharmaceutical Bulletin (2024) Vol. 47, Iss. 3, pp. 698-707
Open Access | Times Cited: 2
Yi Liu, Miho Suzuoki, Hiroki Tanaka, et al.
Biological and Pharmaceutical Bulletin (2024) Vol. 47, Iss. 3, pp. 698-707
Open Access | Times Cited: 2
Reactogenicity Differences between Adjuvanted, Protein-Based and Messenger Ribonucleic Acid (mRNA)-Based COVID-19 Vaccines
Matthew D. Rousculp, Kelly Hollis, Ryan Ziemiecki, et al.
Vaccines (2024) Vol. 12, Iss. 7, pp. 802-802
Open Access | Times Cited: 2
Matthew D. Rousculp, Kelly Hollis, Ryan Ziemiecki, et al.
Vaccines (2024) Vol. 12, Iss. 7, pp. 802-802
Open Access | Times Cited: 2
Effectiveness of different booster vaccine combinations against SARS-CoV-2 during a six-month follow-up in Mexico and Argentina
Arnulfo Garza-Silva, Diego Rivera-Salinas, Andrea Rivera-Cavazos, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Arnulfo Garza-Silva, Diego Rivera-Salinas, Andrea Rivera-Cavazos, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
RNA Vaccines: Yeast as a Novel Antigen Vehicle
Anna Jéssica Duarte Silva, Mylenna Máyra Gois Souza, Larissa Silva de Macêdo, et al.
(2023)
Open Access | Times Cited: 3
Anna Jéssica Duarte Silva, Mylenna Máyra Gois Souza, Larissa Silva de Macêdo, et al.
(2023)
Open Access | Times Cited: 3
A case of generalized pustular psoriasis complicated by acute respiratory distress syndrome after COVID‐19 vaccination
Ayaka Itami, Tomomitsu Miyagaki, Shuhei Mitsuishi, et al.
Journal of the European Academy of Dermatology and Venereology (2023) Vol. 37, Iss. 12
Closed Access | Times Cited: 1
Ayaka Itami, Tomomitsu Miyagaki, Shuhei Mitsuishi, et al.
Journal of the European Academy of Dermatology and Venereology (2023) Vol. 37, Iss. 12
Closed Access | Times Cited: 1
Comparative Analysis of Adverse Event Rates and Severity Following COVID-19 mRNA Vaccinations Among SARS-CoV-2 Naïve Nursing Home Residents and Staff
Masae Itamochi, Shunsuke Yazawa, Yumiko Saga, et al.
Research Square (Research Square) (2024)
Open Access
Masae Itamochi, Shunsuke Yazawa, Yumiko Saga, et al.
Research Square (Research Square) (2024)
Open Access
Is It Time to Re-Evaluate?
Thomas Kieber‐Emmons
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy (2023) Vol. 42, Iss. 6, pp. 187-188
Closed Access
Thomas Kieber‐Emmons
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy (2023) Vol. 42, Iss. 6, pp. 187-188
Closed Access
